Gullberg R M, Homann S R, Phair J P
Section of Infectious Disease, Northwestern University Medical School, Chicago, Illinois 60611.
Rev Infect Dis. 1989 Jan-Feb;11(1):74-85. doi: 10.1093/clinids/11.1.74.
Seventy-five cases of enterococcal bacteremia were analyzed retrospectively. Most patients had serious underlying disease and blood cultures became positive on an average of 27 days after admission. Polymicrobial bacteremia occurred in one-third of the patients. Twenty-two (30%) of the patients died during hospitalization; nine of these deaths were directly due to enterococcal bacteremia. Metastatic infections occurred in seven patients, including five with endocarditis. More than 40% of the patients were receiving antibiotic therapy at the time of bacteremia; cephalosporins were being administered to 56% of these. Thirty-eight patients were treated with two antibiotics. The commonest regimen was ampicillin and gentamicin; 90% of these patients responded. Eighteen patients were treated with only one antibiotic; 89% of these patients responded. Nineteen patients received no antibiotic therapy; the majority of these patients responded despite lack of therapy. Two-drug regimens are not always required for the treatment of enterococcal bacteremia, and treatment must be tailored to the particular clinical situation.
对75例肠球菌血症病例进行了回顾性分析。大多数患者有严重的基础疾病,血培养平均在入院后27天呈阳性。三分之一的患者发生了多微生物菌血症。22例(30%)患者在住院期间死亡;其中9例死亡直接归因于肠球菌血症。7例患者发生了转移性感染,包括5例心内膜炎患者。超过40%的患者在发生菌血症时正在接受抗生素治疗;其中56%的患者正在使用头孢菌素。38例患者接受了两种抗生素治疗。最常用的治疗方案是氨苄西林和庆大霉素;这些患者中有90%有反应。18例患者仅接受了一种抗生素治疗;这些患者中有89%有反应。19例患者未接受抗生素治疗;尽管未接受治疗,但这些患者中的大多数有反应。治疗肠球菌血症并不总是需要两药联合方案,治疗必须根据具体的临床情况进行调整。